Critical Comparison: Acutus Medical (NASDAQ:AFIB) & Fresenius SE & Co. KGaA (OTCMKTS:FSNUY)

Acutus Medical (NASDAQ:AFIB) and Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, institutional ownership, dividends, profitability and earnings.

Profitability

This table compares Acutus Medical and Fresenius SE & Co. KGaA’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Acutus Medical	-166.79%	-54.97%	-13.82%
Fresenius SE & Co. KGaA	0.71%	4.88%	2.02%

Risk & Volatility

Acutus Medical has a beta of 0.03, indicating that its share price is 97% less volatile than the S&P 500. Comparatively, Fresenius SE & Co. KGaA has a beta of 1.06, indicating that its share price is 6% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and price targets for Acutus Medical and Fresenius SE & Co. KGaA, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Acutus Medical	0	0	0	0	N/A
Fresenius SE & Co. KGaA	0	2	2	0	2.50

Valuation and Earnings

This table compares Acutus Medical and Fresenius SE & Co. KGaA’s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Acutus Medical	$7.16 million	0.20	-$81.66 million	N/A	N/A
Fresenius SE & Co. KGaA	$24.01 billion	0.71	-$639.61 million	N/A	N/A

Acutus Medical has higher earnings, but lower revenue than Fresenius SE & Co. KGaA.

Insider & Institutional Ownership

56.9% of Acutus Medical shares are held by institutional investors. 5.2% of Acutus Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Fresenius SE & Co. KGaA beats Acutus Medical on 7 of the 10 factors compared between the two stocks.

About Acutus Medical

Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

About Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.